Tempest Therapeutics, Inc. (TPST) annual balance sheet — 14-year assets, liabilities & equity history
Tempest Therapeutics, Inc. (TPST) balance sheet — 14-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 |
|---|
| Total Current Assets | 1.7M | 8.27M | 31.47M | 40.36M | 32.95M | 68.96M | 19.82M | 71.13M | 83.42M | 19.74M | 116.44M | 129.86M | 61.88M | 45.08M | 31.96M |
| Cash & Short-Term Investments | 779K | 7.71M | 30.27M | 39.23M | 31.23M | 51.83M | 18.82M | 63.51M | 77.72M | 67.2M | 114.39M | 126.86M | 60.23M | 44.43M | 31.39M |
| Cash Only | 779K | 7.71M | 30.27M | 39.23M | 31.23M | 51.83M | 18.82M | 63.51M | 73.33M | 15.7M | 43.93M | 43.42M | 6.41M | 18.08M | 14.78M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.38M | 51.5M | 70.46M | 83.44M | 53.82M | 26.35M | 16.61M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 450K | 15M | 260K | 1.28M | 2.33M | 1.03M | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | 1.28K | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 355K | 535K | 96K | 263K | 553K | 59K | 6.34M | 3.37M | 1.58M | 2.06M | 3M | 1.65M | 650K | 574K |
| Total Non-Current Assets | 7.94M | 8.66M | 10.01M | 11.24M | 13.14M | 4.28M | 3.04M | 3.84M | 652K | 74K | 6.1M | 8.75M | 3.69M | 2.47M | 849K |
| Property, Plant & Equipment | 7.43M | 8.14M | 9.53M | 10.79M | 12.71M | 4.16M | 2.99M | 3.33M | 0 | 3.11M | 5.57M | 8.31M | 3.37M | 880K | 756K |
| Fixed Asset Turnover | 0.00x | - | - | - | - | - | - | - | - | 0.09x | 0.12x | 0.03x | 2.89x | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 388K | 0 | 388K | 0 | 0 | 0 | 0 | 0 | 439K | 146K | 504K | 439K | 0 | 1.5M | 0 |
| Other Non-Current Assets | 501K | 517K | 97K | 448K | 429K | 111K | 51K | 507K | 213K | -3.19M | 23K | 0 | 327K | 88K | 93K |
| Total Assets | 9.63M | 16.93M | 41.49M | 51.6M | 46.09M | 73.24M | 22.86M | 74.97M | 84.07M | 19.81M | 122.54M | 138.61M | 65.57M | 47.55M | 32.81M |
| Asset Turnover | 0.00x | - | - | - | - | - | - | - | - | 0.01x | 0.01x | 0.00x | 0.15x | - | - |
| Asset Growth % | -235.81% | -59.19% | -19.6% | 11.96% | -37.07% | 220.33% | -69.5% | -10.83% | 324.36% | -83.83% | -11.59% | 111.39% | 37.92% | 44.89% | - |
| Total Current Liabilities | 4.45M | 3.31M | 14.22M | 9.41M | 7.28M | 20.03M | 3.22M | 12.52M | 9.82M | 4.09M | 13.21M | 11.24M | 10.17M | 5.77M | 2.09M |
| Accounts Payable | 2M | 1.04M | 2.45M | 845K | 1.11M | 991K | 1.07M | 1.5M | 2M | 2.24M | 2.18M | 3.35M | 2.52M | 1.65M | 875K |
| Days Payables Outstanding | 18.68 | - | 2.3K | - | - | - | 479.65 | - | 22.79K | 29.23K | 147.53 | 544.01 | 2.04K | 2.61K | 3.43K |
| Short-Term Debt | 0 | 0 | 6.35M | 4.29M | 0 | 0 | 0 | 1.96M | 189K | 174K | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 334K | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 147K | 1.76M | 1.79M | 1.25M | 912K | 774K | 7.02M | 7.63M | 2.29M | 11.03M | 7.89M | 7.65M | 4.12M | 1.21M |
| Current Ratio | 0.38x | 2.50x | 2.21x | 4.29x | 4.53x | 3.44x | 6.15x | 5.68x | 8.50x | 4.82x | 8.82x | 11.55x | 6.08x | 7.81x | 15.32x |
| Quick Ratio | 0.38x | 2.50x | 2.21x | 4.29x | 4.53x | 3.44x | 6.15x | 5.68x | 8.50x | 4.82x | 8.82x | 11.55x | 6.08x | 7.81x | 15.32x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 6.27M | 6.95M | 8.14M | 15.42M | 20.7M | 17.09M | 88.43M | 2.58M | 1.14M | 738K | 1.12M | 520K | 73K | 70K | 7K |
| Long-Term Debt | 0 | 6.95M | 0 | 6.26M | 10.37M | 15.07M | 0 | 168K | 383K | 599K | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 13.53M | 0 | 8.14M | 9.16M | 10.33M | 2.03M | 1.73M | 2.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 86.71M | 16K | 752K | 139K | 1.12M | 520K | 73K | 70K | 7K |
| Total Liabilities | 10.72M | 10.26M | 22.36M | 24.84M | 27.98M | 37.12M | 91.66M | 15.1M | 10.95M | 4.83M | 14.32M | 11.76M | 10.25M | 5.84M | 2.09M |
| Total Debt | 7.56M | 8.14M | 15.37M | 20.66M | 22.11M | 18.54M | 2.44M | 4.52M | 572K | 773K | 0 | 0 | 0 | 0 | 0 |
| Net Debt | 6.78M | 434K | -14.9M | -18.57M | -9.12M | -33.29M | -16.38M | -58.99M | -72.76M | -16.85M | -43.93M | -43.42M | -6.41M | -18.08M | -14.78M |
| Debt / Equity | -6.94x | 1.22x | 0.80x | 0.77x | 1.22x | 0.51x | - | 0.08x | 0.01x | 0.05x | - | - | - | - | - |
| Debt / EBITDA | -0.19x | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | -0.17x | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -1759.91x | -125.87x | -30.80x | -19.35x | -21.07x | -21.08x | - | - | -201.81x | - | -124.52x | -167.76x | - | - | - |
| Total Equity | -1.09M | 6.67M | 19.13M | 26.77M | 18.11M | 36.12M | -68.79M | 59.87M | 73.12M | 14.98M | 108.22M | 126.85M | 55.33M | 41.7M | 30.72M |
| Equity Growth % | -313.51% | -65.14% | -28.55% | 47.8% | -49.85% | 152.5% | -214.9% | -18.12% | 388.03% | -86.15% | -14.69% | 129.28% | 32.67% | 35.74% | - |
| Book Value per Share | -0.07 | 1.61 | 0.69 | 1.74 | 20.39 | 123.87 | -2204.20 | 65.52 | 708.99 | 12827.91 | 757.41 | 1053.77 | 549.66 | 414.30 | 15468.78 |
| Total Shareholders' Equity | -1.09M | 6.67M | 19.13M | 26.77M | 18.11M | 36.12M | -68.79M | 58.55M | 70.95M | 2.23M | 108.22M | 126.85M | 55.33M | 41.7M | 30.72M |
| Common Stock | 16K | 5K | 44K | 22K | 11K | 7K | 1K | 18K | 13K | 36K | 36K | 27K | 24K | 18K | 14K |
| Retained Earnings | -275.32M | -233.37M | -207.11M | -165.26M | -135.77M | -100.06M | -71.76M | -208.65M | -164.09M | -136.89M | -250.18M | -167.92M | -94.7M | -45.18M | -16.13M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 165K | 148K | -19K | -60K | -170K | -1.14M | -688K | -6K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.32M | 2.17M | 12.76M | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying TPST stock.
As of 2025, Tempest Therapeutics, Inc. (TPST) had total assets of $16.9M including $8.3M in current assets.
Tempest Therapeutics, Inc. (TPST) carries total debt of $8.1M, offset by $7.7M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Tempest Therapeutics, Inc. (TPST) has total shareholders' equity (book value) of $6.7M ($1.61 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Tempest Therapeutics, Inc. (TPST) reported a current ratio of 2.50x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.